| Ascendis Pharma Switzerland GmbH - Yorvipath 420 μg/1.4 ml, Injektionslösung im Fertigpen |
| 69889 | | 03 | | Yorvipath 420 μg/1.4 ml | | Injektionslösung im Fertigpen | | H05AA05 | | Palopegteriparatide | | 09.12.2025 | | |
|
| Composition |
| palopegteriparatidum 4838 µg corresp. teriparatidum 420 µg, acidum succinicum, mannitolum, metacresolum, natrii hydroxidum, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.4 ml corresp. natrium 10.925 mg. |
| Packungsbestandteile |
| Injektionslösung im Fertigpen | | | | | | Active Agent | Dose |
|---|
| Palopegteriparatidum | 4838 µg correspond Teriparatide 420 µg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Succinic Acid | | Mannitol | | Metacresol | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 2 x 1 | | | B | | No | | 006 | 2 | | | B | | No |
|
